However, studies on prostate cancer indicated a discordant oncogenic role and different molecular mechanisms underlying SOCS2-AS1 action20, thereby suggesting tissue-specific regulation of SOCS2-AS1 expression. Here, SOCS2 is linked to prostate carcinoma.